XENMATRIX AB 1153030

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,other,stu report with the FDA on 2018-04-17 for XENMATRIX AB 1153030 manufactured by Davol Inc., Sub. C.r. Bard, Inc..

Event Text Entries

[105710020] There was no connection that can be made between the reported postoperative complication (seroma) and any problem with the xenmatrix ab graft used to treat the patient. The graft remains implanted. No definitive conclusion can be made at this time. Seroma formation is a known inherent risk of surgery and is identified in the adverse reaction section of the instructions-for-use as a potential complication. A review of the manufacturing records was performed and found that the lot was manufactured to specification. If additional information is provided, a supplemental emdr will be submitted. The information provided by bard represents all of the known information at this time. Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard. Remains implanted.
Patient Sequence No: 1, Text Type: N, H10


[105710021] It was reported that a patient who is part of a clinical study has been diagnosed with a seroma. On (b)(6) 2017 the subject patient underwent repair of a subxiphoid, epigastric hernia using a xenmatrix ab graft. Concomitant procedures were also performed at this time and included, removal of deep foreign bodies, muscle x2, an adjacent tissue transfer and lysis of adhesions. The hernia is noted to be a primary ventral hernia and assessed to be a class 1 (clean) wound site pre operatively. The case was performed in retro rectus fashion with component separation technique (posterior). A tar (transversus abdominis muscle release) technique was utilized. Xenmatrix ab graft was placed with a 5cm graft overlap around the hernia defect. Long-term absorbable monofilament suture was used for perimeter fixation of the graft. The midline fascia was completely closed. The skin was not fully closed and a vacuum assisted closure was performed. Drains were inserted in the right upper quadrant, left upper quadrant and in the subcutaneous space. The drains and vacuum were removed on (b)(6) 2017 and the patient was discharged from the hospital. On (b)(6) 2017 the patient was diagnosed with a seroma. Intervention has not been specified. Crf indicates the ae has been resolved with an end date of (b)(6) 2017. The ae of seroma was assessed by the health professional as being possibly related to the study device and possibly related to the procedure. The seroma was considered a grade 3 with a severity rating of serious.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1213643-2018-01106
MDR Report Key7437250
Report SourceHEALTH PROFESSIONAL,OTHER,STU
Date Received2018-04-17
Date of Report2018-04-17
Date of Event2017-11-24
Date Mfgr Received2018-03-29
Device Manufacturer Date2017-03-17
Date Added to Maude2018-04-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLAURA SUNDBERG
Manufacturer Street100 CROSSINGS BLVD.
Manufacturer CityWARWICK RI 02886
Manufacturer CountryUS
Manufacturer Postal02886
Manufacturer Phone4018258462
Manufacturer G1BARD SHANNON LIMITED -3005636544
Manufacturer StreetSAN GERONIMO INDUSTRIAL PARK LOT #1, ROAD #3, KM 79.7
Manufacturer CityHUMACAO PR 00791
Manufacturer CountryUS
Manufacturer Postal Code00791
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameXENMATRIX AB
Generic NamePORCINE SURGICAL MESH
Product CodePIJ
Date Received2018-04-17
Model NumberNA
Catalog Number1153030
Lot NumberHUBN1973
Device Expiration Date2019-01-28
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerDAVOL INC., SUB. C.R. BARD, INC.
Manufacturer Address100 CROSSINGS BLVD. WARWICK RI 02886 US 02886


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2018-04-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.